Annual report
286A.TEDINET S100VGY6
Period2024-01-01 → 2024-12-31
Filed2025-03-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 117
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥19.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥18.1bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥16.6bn | 2022-01-01 → 2022-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.3bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥1.9bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.8bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.9bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥784m | 2022-01-01 → 2022-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.1bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.7bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.0bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥980m | 2022-01-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.1bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥1.2bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥60.1bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥51.0bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥42.6bn | at 2022-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥41.2bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥39.2bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.0bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥11.8bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.4bn | at 2022-12-31d | Cons. | Net assets |
| Cash and deposits | ¥11.2bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥11.1bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.1bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥209m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥406m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥1.4bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥3.5bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.3bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.0bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥64.4 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.18 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.8 | 2022-01-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥63.12 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥507.67 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥362.04 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥324.44 | at 2022-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 29.9% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.3% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.7% | at 2022-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 14.1% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2022-01-01 → 2022-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 833 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 769 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 699 | at 2022-12-31d | Cons. | Number of employees |
| Revenue | ¥5.6bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥5.4bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥4.0bn | 2022-01-01 → 2022-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.7bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.4bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Operating income | ¥1.1bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Ordinary income | ¥2.1bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥356m | 2022-01-01 → 2022-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥827m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥771m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.1bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Net income | ¥1.8bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥709m | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥1.3bn | 2022-01-01 → 2022-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥565m | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥583m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥36.0bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥29.2bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥22.3bn | at 2022-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥23.5bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥24.9bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥19.2bn | at 2024-12-31 | Standalone | Liabilities |
| Total liabilities | ¥19.2bn | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥16.9bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥10.0bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥9.3bn | at 2022-12-31d | Standalone | Net assets |
| Net assets / equity | ¥7.9bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.3bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.7bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥58.56 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.72 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.24 | 2022-01-01 → 2022-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.91 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.53 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥57.4 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥477.26 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥333.28 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥310.1 | at 2022-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥265.41 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥245.51 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 46.8% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.2% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.6% | at 2022-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.5% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 13.7% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.7% | 2022-01-01 → 2022-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.3% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 37,982,900 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,100 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,100 | at 2022-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,100 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,100 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 167 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 130 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 117 | at 2022-12-31d | Standalone | Number of employees |
| Employees | 119 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 87 | at 2020-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 66
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-01-01 → 2024-12-31 | ¥380,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-12-31 | 11 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-12-31 | ¥63m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-12-31 | ¥63m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-12-31 | −¥140m |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥70m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥1.2bn |
| Comprehensive Medical Management Support Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥309m |
| Comprehensive Medical Management Support Businessreportable segment | employees | at 2024-12-31 | 137 pure |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥6.4bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥6.4bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥9m |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥2.8bn |
| Elderly Care Related Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥514m |
| Elderly Care Related Businessreportable segment | employees | at 2024-12-31 | 594 pure |
| Elderly Care Related Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥6.9bn |
| Elderly Care Related Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥6.9bn |
| Elderly Care Related Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥309m |
| Specially Controlled Medical Device Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥33m |
| Specially Controlled Medical Device Businessreportable segment | employees | at 2024-12-31 | 57 pure |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥6.5bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥6.5bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥485m |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥857m |
| —segment total | employees | at 2024-12-31 | 788 pure |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥19.8bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥19.8bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥9m |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥3.6bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-01-01 → 2024-12-31 | ¥857m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-12-31 | ¥19.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-12-31 | ¥19.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-12-31 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-01-01 → 2023-12-31 | ¥551,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-12-31 | ¥36m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-12-31 | ¥36m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-12-31 | −¥215m |
| Reconciling Itemsreconciling | depreciation | 2023-01-01 → 2023-12-31 | ¥55m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥898m |
| Comprehensive Medical Management Support Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥305m |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥5.4bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥5.4bn |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.0bn |
| Elderly Care Related Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥468m |
| Elderly Care Related Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥6.7bn |
| Elderly Care Related Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥6.7bn |
| Elderly Care Related Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥626m |
| Specially Controlled Medical Device Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥10m |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥6.0bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥6.0bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥377m |
| —segment total | depreciation | 2023-01-01 → 2023-12-31 | ¥783m |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥18.0bn |
| —segment total | revenue external | 2023-01-01 → 2023-12-31 | ¥18.0bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-01-01 → 2023-12-31 | ¥784m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-12-31 | ¥18.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-12-31 | ¥18.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-12-31 | ¥2.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-12-31 | 11 pure |
| Comprehensive Medical Management Support Businessreportable segment | employees | at 2024-12-31 | 118 pure |
| Elderly Care Related Businessreportable segment | employees | at 2024-12-31 | 4 pure |
| —segment total | employees | at 2024-12-31 | 122 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,646
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E12328-000NishimuraYoshikazuMember | 10000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E12328-000SutohShujiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E12328-000NanyeKyoichiMember | 20000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E12328-000SugiyamaFuminoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 22142200 | |
| Audit fees reporting company | Prior1YearDuration | 23000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 25000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | 1000000 | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | 23000000 | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | 23000000 | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 46000000 | JPY |
| Non audit fees total | Prior1YearDuration | － | JPY |
| Audit fees total | CurrentYearDuration | 48000000 | JPY |
| Non audit fees total | CurrentYearDuration | 1000000 | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsExcludingAuditAndSupervisoryCommitteeExcludingOutsideDirectorMember | 99600000 | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000OutsideDirectorsExcludingAuditAndSupervisoryCommitteeMember | － | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsExcludingAuditAndSupervisoryCommitteeExcludingOutsideDirectorMember | 99600000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000OutsideDirectorsExcludingAuditAndSupervisoryCommitteeMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsExcludingAuditAndSupervisoryCommitteeExcludingOutsideDirectorMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000OutsideDirectorsExcludingAuditAndSupervisoryCommitteeMember | － | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsExcludingAuditAndSupervisoryCommitteeExcludingOutsideDirectorMember | － | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000OutsideDirectorsExcludingAuditAndSupervisoryCommitteeMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsExcludingAuditAndSupervisoryCommitteeExcludingOutsideDirectorMember | 3 | |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000OutsideDirectorsExcludingAuditAndSupervisoryCommitteeMember | － | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsAppointedAsAuditMember | 15600000 | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000OutsideDirectorsAppointedAsAuditAndSupervisoryCommitteeMember | 15600000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsAppointedAsAuditMember | 15600000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000OutsideDirectorsAppointedAsAuditAndSupervisoryCommitteeMember | 15600000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsAppointedAsAuditMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000OutsideDirectorsAppointedAsAuditAndSupervisoryCommitteeMember | － | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsAppointedAsAuditMember | － | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000OutsideDirectorsAppointedAsAuditAndSupervisoryCommitteeMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsAppointedAsAuditMember | 3 | |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000OutsideDirectorsAppointedAsAuditAndSupervisoryCommitteeMember | 3 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsMember | 115200000 | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsMember | 15600000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsMember | 115200000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsMember | 15600000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsMember | － | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsMember | － | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E12328-000DirectorsMember | 6 | |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsMember | 3 | |
| Number of issues shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 2 | |
| Carrying amount shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 20900000 | JPY |
| Number of issues shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 1 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |